The burgeoning popularity of semaglutide , initially for metabolic conditions, is creating significant buzz within the British Isles, prompting a notable shift in medication trends. Obtaining these compounds remains a complex landscape, with NHS approval currently limited and private clinics offering treatment at a higher cost . Questions are being